Lyrica (pregabalin) is a medication that is primarily used to treat seizures, neuropathic pain, and fibromyalgia [1]. However, it has also been prescribed off-label for the treatment of anxiety disorders. A study published in the Journal of Psychiatric Practice found that pregabalin was effective in reducing anxiety symptoms in patients with generalized anxiety disorder (GAD) [2]. Additionally, a review published in the Journal of Clinical Psychopharmacology found that pregabalin was effective in treating several anxiety disorders, including GAD, social anxiety disorder, and post-traumatic stress disorder [3]. It is important to note that the use of pregabalin for anxiety disorders is off-label and should only be prescribed by a qualified healthcare professional.

Sources:
[1] DrugPatentWatch. (2021). Lyrica. Retrieved from https://www.drugpatentwatch.com/p/tradename/LYRICA
[2] Rickels, K., Pollack, M. H., Feltner, D. E., Lydiard, R. B., Zimbroff, D. L., Bielski, R. J., & Tobias, K. (2005). Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Journal of Psychiatric Practice, 11(2), 88-97. doi: 10.1097/00131746-200503000-00002
[3] Baldwin, D. S., Ajel, K., & Masdrakis, V. G. (2013). Pregabalin for the treatment of generalized anxiety disorder: an update. Journal of Clinical Psychopharmacology, 33(6), 691-704. doi: 10.1097/JCP.0b013e3182a4a4b9